In other countries
The same active substances on other registers, the same brand first.
- Naropin 10MG-ML AmpSaudi Arabia · AstraZenecaSame form
- Naropin 10MG-ML AmpSaudi Arabia · AstraZenecaSame form
- Naropin 2MG-ML Plastic AmpSaudi Arabia · AstraZenecaSame form
- NaropinCanada · 10 MG / ML · Solution · Aspen Pharmacare Canada INC.Same substance
- NaropinCanada · 5 MG / ML · Solution · Aspen Pharmacare Canada INC.Same substance
- NaropinCanada · 2 MG / ML · Solution · Aspen Pharmacare Canada INC.Same substance
- ROPIVACAINA ALTAN 10 mg/ml SOLUCION INYECTABLE EFGSpain · 100 mg · solución inyectable · Altan Pharmaceuticals SaSame substance
- ROPIVACAINA ALTAN 2 mg/ml SOLUCION INYECTABLE EFGSpain · 20 mg · solución inyectable · Altan Pharmaceuticals S.A.Same substance
- ROPIVACAINA ALTAN 2 mg/ml SOLUCION PARA PERFUSION EFGSpain · 2 g · solución para perfusión · Altan Pharmaceuticals SaSame substance
- Ropivacaine Molteni 2 mg/ml otopina za infuziju*Croatia · otopina za infuziju · L. Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A., Strada Statale 67, Fraz. Granatieri, Scandicci, Firenza, ItalijaSame substance
- Ropivacaine Molteni 7,5 mg/ml otopina za injekciju*Croatia · otopina za injekciju · L. Molteni & C. dei F.lli Alitti Societa di Esercizio S.p.A., Strada Statale 67, Fraz. Granatieri, Scandicci, Firenza, ItalijaSame substance
- NaropinaItaly · Soluzione iniettabile · Sandoz S.P.A.Same substance
- Ropivacaina B. BraunItaly · Soluzione iniettabile · B. Braun Melsungen AGSame substance
- Ropivacaina Cloridrato AltanItaly · Soluzione iniettabile · Altan Pharmaceuticals S.A.Same substance
- Naropin 10 mg/ml, oplossing voor injectie voor perineurale en epidurale toedieningNetherlands · Oplossing voor injectie · Sandoz B.V.Same substance
- Naropin 2 mg/ml, oplossing voor injectie voor perineurale en epidurale toedieningNetherlands · Oplossing voor injectie of infusie · Sandoz B.V.Same substance
- Naropin 5 mg/ml, oplossing voor injectie voor intrathecale toedieningNetherlands · Oplossing voor injectie · Sandoz B.V.Same substance
- Ropivacaine KabiNew Zealand · Inj 7.5 mg per ml, 20 ml ampouleSame substance
- Ropivacaine KabiNew Zealand · Inj 2 mg per ml, 100 ml bagSame substance
- Ropivacaine KabiNew Zealand · Inj 10 mg per ml, 10 ml ampouleSame substance
- ROPIVACAINA KABI 10 mg/mlRomania · 10mg/ml · sol. inj. · Fresenius Kabi Romania S.R.L.Same substance
- ROPIVACAINA KABI 2 mg/mlRomania · 2mg/ml · sol. inj. · Fresenius Kabi Romania S.R.L.Same substance
- Naropin Infusion 0.2%Singapore · 2 mg/ml · injection · DCH Auriga SingaporeSame substance
- Naropin Injection 1%Singapore · 10 mg/ml · injection · DCH Auriga SingaporeSame substance
- Ropivacaine-Aft Solution for Infusion 0.2% W/VSingapore · 2.0 mg/mL · infusion, solution · Apex Pharma Marketing Pte. LTD.Same substance
- NaropinUnited States · 100MG/10ML, 100MG/20ML, 150MG/20ML … · solution · Fresenius Kabi USASame substance
- Ropivacaine HydrochlorideUnited States · 100MG/10ML, 100MG/20ML, 150MG/20ML … · solution · Somerset Theraps LLCSame substance
- Ropivacaine HydrochlorideUnited States · 5MG/ML · injectable · Navinta LLCSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Ropivacaine
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 9 Feb 2026
- Registration
- 103870090
- Marketing authorisation holder
- Hypofarma - Instituto de Hypodermia e Farmácia Ltda
- Procedure
- Registered